YM-7555 vaccine

N/A

Report date: 2025/01/26 16:15:34

Base Information

Drug NameYM-7555 vaccine

Drug Alias NameA-beta-x4-Fc-tau-x4 vaccineDNA vaccine targeting amyloid-beta species and tau peptides (Tokyo Metropolitan Institute of Medical Science)third generation DNA vaccines (Tokyo Metropolitan Institute of Medical Science)

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionBeta amyloid A4 protein inhibitorsMicrotubule-associated protein tau inhibitors

TargetsBeta amyloid A4 proteinMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTokyoto Igaku Kenkyu Kiko

China Registration ClassN/A

Develop Information

Active CompaniesVitruvian Biomedical

Inactive CompaniesTokyoto Igaku Kenkyu Kiko

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A